TNF and inflammatory bowel disease: For the better clinical translation of autophagy modulation strategies, the support of more clinical trials is now needed, to assess the unintended consequences or adverse effects of therapeutic strategies, to utilize extended studies of autophagy modulators in TNF-α antibody-resistant IBD, and to accurately monitor available biomarkers of mucosal healing in IBD patients (184).